Skip to content
- Patient Experience with a Gynecologic Oncology-Initiated Genetic Testing Model for Women with Tubo-Ovarian Cancer.
- Bercovitch Sadinsky M, Power J, Ambrosio E, Palma L, Zeng X, Foulkes WD, Weber E.
- Curr Oncol. 2022 May 15;29(5):3565-3575. doi: 10.3390/curroncol29050288.
- Germline sequencing for presumed germline pathogenic variants via tumor-only comprehensive genomic profiling.
- Kondo T, Yamamoto Y, Fukuyama K, Kanai M, Yamada A, Matsubara J, Quy PN, Yoshioka M, Yamada T, Minamiguchi S, Matsumoto S, Kosugi S, Muto M.
- Int J Clin Oncol. 2022 May 14. doi: 10.1007/s10147-022-02176-y. Epub ahead of print.
- CBCRisk-Black: a personalized contralateral breast cancer risk prediction model for black women.
- Sajal IH, Chowdhury M, Wang T, Euhus D, Choudhary PK, Biswas S.
- Breast Cancer Res Treat. 2022 May 13. doi: 10.1007/s10549-022-06612-5. Epub ahead of print.
- Exploiting replication gaps for cancer therapy.
- Cong K, Cantor SB.
- Mol Cell. 2022 May 4:S1097-2765(22)00386-0. doi: 10.1016/j.molcel.2022.04.023. Epub ahead of print.